Drug search by name

Pioglitazone and Metformin Extended-Release Tablets and Bladder cancer

Result of checking the interaction of drug Pioglitazone and Metformin Extended-Release Tablets and disease Bladder cancer for safety when used together.

Check result:

Pioglitazone and Metformin Extended-Release Tablets <> Bladder cancer

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

There are insufficient data to determine if pioglitazone has an effect on preexisting bladder tumors or if it can cause bladder cancer. However, the manufacturer does not recommend the use of pioglitazone in patients with active bladder cancer. In patients with history of bladder cancer the benefit of treatment versus the risk of cancer recurrence during treatment should be considered.

Pioglitazone and Metformin Extended-Release Tablets

Generic Name: metformin / pioglitazone

Brand Name: Actoplus Met, Actoplus Met XR

Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin

What is Pioglitazone and Metformin Extended-Release Tablets?